UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Triple-Negative Breast Cancer: Epidemiology and Management Options

Drugs (New York, N.Y.), 2010-01, Vol.70 (17), p.2247-2258

Dawood, Shaheenah

2010

Volltextzugriff (PDF)

Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle East

Frontiers in oncology, 2024, Vol.14, p.1426941

2024

Volltextzugriff (PDF)

Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI]

Current women's health reviews, 2024-01, Vol.20 (1)

2024

Volltextzugriff (PDF)

Use of PARPi among patients with HER2+ve MBC: Results from a real world dataset

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13044-e13044

2023

Volltextzugriff (PDF)

Impact of use of CDK4/6i and neratinib among patients with HER2 +ve MBC: Results from a real world dataset

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13046-e13046

2023

Volltextzugriff (PDF)

Real-world PARPi treatment patterns and outcomes among patients with metastatic breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e13005-e13005

2022

Volltextzugriff (PDF)

Use of RET inhibitors among patients with advanced NSCLC: A real-world evidence analysis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9079-9079

2022

Volltextzugriff (PDF)

Comparison of biomarkers among 34,855 GI cancer samples show heterogeneity of tumor types

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14287-e14287

Dawood, Shaheenah S.

2019

Volltextzugriff (PDF)

Fulvestrant and elacestrant utilization on prognostic outcome of patients with HR+ve/HER2-ve MBC

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13094-e13094

2024

Volltextzugriff (PDF)

Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer - Proceedings from breast cancer expert group meeting

BMC proceedings, 2021-08, Vol.15 (Suppl 10), p.15-15, Article 15

2021

Volltextzugriff (PDF)

Impact of race on the utilization and efficacy of CDK4/6i: Result from a real world database

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e13036-e13036

2021

Volltextzugriff (PDF)

Efficacy of CDK4/6i in the visceral crisis setting: Result from a real-world database

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1047-1047

2021

Volltextzugriff (PDF)

Comparison of biomarkers among 34855 GI cancer samples shows heterogeneity of tumor types

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.217-217

Dawood, Shaheenah S.

2019

Volltextzugriff (PDF)

Using circulating tumor cells to guide therapy in breast cancer: could this replace biopsies?

Pharmacogenomics, 2015-05, Vol.16 (7), p.669-672

2015

Volltextzugriff (PDF)

Novel biomarkers of metastatic cancer

Expert review of molecular diagnostics, 2010-07, Vol.10 (5), p.581-590

Dawood, Shaheenah

2010

Volltextzugriff (PDF)

Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA (ctDNA) in Routine Clinical Practice

Oncology, 2024-09, p.1-24

2024

Volltextzugriff (PDF)

Effect of breast tumor subtype and site of distant metastatic disease on prognostic outcome among patients with brain metastases and stage IV denovo breast cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1034-1034

2018

Volltextzugriff (PDF)

Efficacy of oral selective estrogen receptor degraders (SERD)s in the treatment of estrogen receptor positive (ER+), HER2-negative metastatic breast cancer (MBC): A stratified analysis of the ESR1 wild type (wt) and mutant (mt) subgroups

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1096-1096

2023

Volltextzugriff (PDF)

Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early

Cancer, 2011-05, Vol.117 (9), p.1819-1826

2011

Volltextzugriff (PDF)

Indirect treatment comparison of first-line CDK4/6-inhibitors in post-menopausal patients with HR+/HER2- metastatic breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1071-1071

2023

Volltextzugriff (PDF)

Analysis of hereditary cancer syndromes in patients from the United Arab Emirates

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13509-e13509

2018

Volltextzugriff (PDF)

Retrospective Study of 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data

The Journal of nuclear medicine (1978), 2009-02, Vol.50 (2), p.231-238

2009

Volltextzugriff (PDF)

Circulating tumor cells in metastatic breast cancer

Cancer, 2008-11, Vol.113 (9), p.2422-2430

2008

Volltextzugriff (PDF)

Importance of clinical decision making in precision oncology: Discordance in recommendation between next generation sequencing test vendor and molecular tumour board in India

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15050-e15050

2023

Volltextzugriff (PDF)

Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT

Radiology, 2008-04, Vol.247 (1), p.189-196

2008

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

Humans
(13)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Breast Cancer
(9)
Female
(9)
Adult
(6)
Breast Neoplasms - Pathology
(5)
Prognosis
(5)
Middle Aged
(4)
Tumors
(4)
Aged
(3)
Breast Neoplasms - Diagnosis
(3)
Breast Neoplasms - Therapy
(3)
Circulating Tumor Cells
(3)
Pathology
(3)
Antineoplastic Agents - Therapeutic Use
(2)
Antineoplastic Combined Chemotherapy Protocols
(2)
Biological And Medical Sciences
(2)
Brain Neoplasms - Secondary
(2)
Breast Neoplasms - Blood
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Triple-Negative Breast Cancer: Epidemiology and Management Options

Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle East

Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI]

Use of PARPi among patients with HER2+ve MBC: Results from a real world dataset

Impact of use of CDK4/6i and neratinib among patients with HER2 +ve MBC: Results from a real world dataset

Real-world PARPi treatment patterns and outcomes among patients with metastatic breast cancer

Use of RET inhibitors among patients with advanced NSCLC: A real-world evidence analysis

Comparison of biomarkers among 34,855 GI cancer samples show heterogeneity of tumor types

Fulvestrant and elacestrant utilization on prognostic outcome of patients with HR+ve/HER2-ve MBC

Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer - Proceedings from breast cancer expert group meeting

Impact of race on the utilization and efficacy of CDK4/6i: Result from a real world database

Efficacy of CDK4/6i in the visceral crisis setting: Result from a real-world database

Comparison of biomarkers among 34855 GI cancer samples shows heterogeneity of tumor types

Using circulating tumor cells to guide therapy in breast cancer: could this replace biopsies?

Novel biomarkers of metastatic cancer

Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA (ctDNA) in Routine Clinical Practice

Effect of breast tumor subtype and site of distant metastatic disease on prognostic outcome among patients with brain metastases and stage IV denovo breast cancer

Efficacy of oral selective estrogen receptor degraders (SERD)s in the treatment of estrogen receptor positive (ER+), HER2-negative metastatic breast cancer (MBC): A stratified analysis of the ESR1 wild type (wt) and mutant (mt) subgroups

Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early

Indirect treatment comparison of first-line CDK4/6-inhibitors in post-menopausal patients with HR+/HER2- metastatic breast cancer

Analysis of hereditary cancer syndromes in patients from the United Arab Emirates

Retrospective Study of 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data

Circulating tumor cells in metastatic breast cancer

Importance of clinical decision making in precision oncology: Discordance in recommendation between next generation sequencing test vendor and molecular tumour board in India

Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT

Aktive Filter

Suchergebnisse filtern